AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

NuCana plc (NASDAQ: NCNA) faces heightened delisting risk. The company disclosed that on July 8, 2025 it received a second notice from Nasdaq after its American Depositary Shares closed below $0.10 for 10 consecutive trading days (period ended July 7, 2025). This follows an earlier June 18, 2025 notice for falling below the $1.00 minimum bid price, which granted NuCana until December 15, 2025 to regain compliance. Under Nasdaq Listing Rule 5810(c)(3)(A)(iii), falling below $0.10 triggers imminent delisting unless the issuer requests a hearing.
NuCana intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will automatically stay any suspension or delisting action pending the Panel’s decision, giving management additional time to present a compliance plan or pursue corporate actions (e.g., reverse split) to restore the share price.

No financial results, operational updates, or transactions were included; the 6-K focuses solely on the listing status. The information is incorporated by reference into the company’s existing Form F-3 and S-8 registration statements.

NuCana plc (NASDAQ: NCNA) è a rischio aumentato di esclusione dalla quotazione. La società ha comunicato che l'8 luglio 2025 ha ricevuto un secondo avviso da Nasdaq dopo che le sue American Depositary Shares hanno chiuso al di sotto di $0,10 per 10 giorni di contrattazione consecutivi (periodo terminato il 7 luglio 2025). Questo segue un avviso precedente del 18 giugno 2025 per essere scese sotto il prezzo minimo di offerta di $1,00, che ha concesso a NuCana tempo fino al 15 dicembre 2025 per tornare in conformità. Secondo la Regola di Quotazione Nasdaq 5810(c)(3)(A)(iii), scendere sotto i $0,10 comporta un'imminente esclusione dalla quotazione a meno che l’emittente non richieda un'udienza.
NuCana intende richiedere tempestivamente un'udienza davanti al Nasdaq Hearings Panel. La richiesta di udienza sospenderà automaticamente qualsiasi azione di sospensione o esclusione in attesa della decisione del Panel, concedendo alla direzione ulteriore tempo per presentare un piano di conformità o intraprendere azioni societarie (ad esempio, frazionamento inverso) per ripristinare il prezzo delle azioni.

Non sono stati inclusi risultati finanziari, aggiornamenti operativi o transazioni; il modulo 6-K si concentra esclusivamente sullo stato della quotazione. Le informazioni sono incorporate per riferimento nelle dichiarazioni di registrazione Form F-3 e S-8 esistenti della società.

NuCana plc (NASDAQ: NCNA) enfrenta un riesgo elevado de exclusión de la cotización. La compañía informó que el 8 de julio de 2025 recibió un segundo aviso de Nasdaq después de que sus American Depositary Shares cerraran por debajo de $0.10 durante 10 días hábiles consecutivos (periodo finalizado el 7 de julio de 2025). Esto sigue a un aviso anterior del 18 de junio de 2025 por caer por debajo del precio mínimo de oferta de $1.00, que otorgó a NuCana hasta el 15 de diciembre de 2025 para recuperar el cumplimiento. Según la Regla de Cotización Nasdaq 5810(c)(3)(A)(iii), caer por debajo de $0.10 genera una exclusión inminente a menos que el emisor solicite una audiencia.
NuCana tiene la intención de solicitar oportunamente una audiencia ante el Nasdaq Hearings Panel. La solicitud de audiencia suspenderá automáticamente cualquier acción de suspensión o exclusión mientras se espera la decisión del Panel, dando a la dirección tiempo adicional para presentar un plan de cumplimiento o realizar acciones corporativas (por ejemplo, una división inversa) para restaurar el precio de las acciones.

No se incluyeron resultados financieros, actualizaciones operativas ni transacciones; el formulario 6-K se centra exclusivamente en el estado de la cotización. La información se incorpora por referencia en las declaraciones de registro Form F-3 y S-8 existentes de la compañía.

NuCana plc (NASDAQ: NCNA)ëŠ� ìƒìž¥íì§€ 위험ì� 높아지ê³� 있습니다. 회사ëŠ� 2025ë…� 7ì›� 8ì�, 미국예íƒì¦ì„œ(ADS)ì� 종가가 10거래ì� ì—°ì†ìœ¼ë¡œ $0.10 미만ì� 기ë¡í•� ê²ƒì— ëŒ€í•� Nasdaq으로부í„� ë‘� 번째 통지ë¥� 받았다고 ë°í˜”습니ë‹�(기간 종료ì�: 2025ë…� 7ì›� 7ì�). ì´ëŠ” 2025ë…� 6ì›� 18ì¼ì— $1.00ì� 최소 ìž…ì°°ê°€ 미만으로 떨어ì§� ê²ƒì— ëŒ€í•� ì²� 번째 통지ì—� ì´ì€ 것입니다. ì� 통지ì—� ë”°ë¼ ±·³Ü°ä²¹²Ô²¹µç� 2025ë…� 12ì›� 15ì¼ê¹Œì§€ 규정 준수를 회복해야 합니ë‹�. Nasdaq ìƒìž¥ 규칙 5810(c)(3)(A)(iii)ì—� 따르ë©� $0.10 미만으로 떨어지ë©� 발행사가 청문회를 요청하지 않는 í•� 즉ê°ì ì¸ ìƒìž¥í지가 촉발ë©ë‹ˆë‹�.
±·³Ü°ä²¹²Ô²¹µç� ì ì‹œì—� Nasdaq 청문íš� 패ë„ì—� 청문íš� 요청ì� í•� 계íšìž…니ë‹�. 청문íš� ìš”ì²­ì€ íŒ¨ë„ì� ê²°ì •ì� ë‚´ë ¤ì§� 때까지 모든 ì •ì§€ ë˜ëŠ” ìƒìž¥íì§€ 조치ë¥� ìžë™ìœ¼ë¡œ 중단시키ë©�, ê²½ì˜ì§„ì—ê²� 준ìˆ� 계íšì� 제시하거ë‚� 주가 회복ì� 위한 기업 조치(ì˜�: 액면병합)ë¥� 추진í•� 추가 시간ì� 제공합니ë‹�.

재무 실ì , ìš´ì˜ ì—…ë°ì´íЏ ë˜ëŠ” 거래 ê´€ë � ë‚´ìš©ì€ í¬í•¨ë˜ì§€ 않았으며, 6-K 보고서는 ìƒìž¥ ìƒíƒœì—ë§Œ 집중ë˜ì–´ 있습니다. ì� ì •ë³´ëŠ� 회사ì� 기존 Form F-3 ë°� S-8 ë“±ë¡ ì„œë¥˜ì—� 참조ë¡� í¬í•¨ë©ë‹ˆë‹�.

NuCana plc (NASDAQ : NCNA) fait face à un risque accru de radiation. La société a révélé que, le 8 juillet 2025, elle a reçu un second avis de Nasdaq après que ses American Depositary Shares ont clôturé en dessous de 0,10 $ pendant 10 jours de bourse consécutifs (période terminée le 7 juillet 2025). Cela fait suite à un premier avis du 18 juin 2025 pour être tombé en dessous du prix d'offre minimum de 1,00 $, accordant à NuCana jusqu'au 15 décembre 2025 pour se remettre en conformité. Selon la règle de cotation Nasdaq 5810(c)(3)(A)(iii), un cours inférieur à 0,10 $ déclenche une radiation imminente, sauf si l’émetteur demande une audience.
NuCana a l'intention de demander en temps utile une audience devant le Nasdaq Hearings Panel. La demande d’audience suspendra automatiquement toute suspension ou radiation en attendant la décision du Panel, offrant à la direction un délai supplémentaire pour présenter un plan de conformité ou engager des actions d’entreprise (par exemple, un regroupement d’actions) pour rétablir le cours de l’action.

Aucun résultat financier, mise à jour opérationnelle ou transaction n’a été inclus ; le formulaire 6-K se concentre uniquement sur le statut de la cotation. Les informations sont incorporées par référence dans les déclarations d’enregistrement Form F-3 et S-8 existantes de la société.

NuCana plc (NASDAQ: NCNA) steht vor einem erhöhten Risiko der Delistung. Das Unternehmen gab bekannt, dass es am 8. Juli 2025 eine zweite Mitteilung von Nasdaq erhalten hat, nachdem seine American Depositary Shares an 10 aufeinanderfolgenden Handelstagen unter $0,10 geschlossen hatten (Zeitraum endete am 7. Juli 2025). Dies folgt auf eine frühere Mitteilung vom 18. Juni 2025 wegen Unterschreitens des Mindestgebotspreises von $1,00, die NuCana bis zum 15. Dezember 2025 Zeit gab, die Einhaltung wiederherzustellen. Nach Nasdaq Listing Rule 5810(c)(3)(A)(iii) führt ein Kurs unter $0,10 zu einer unmittelbar bevorstehenden Delistung, sofern der Emittent keine Anhörung beantragt.
NuCana beabsichtigt, rechtzeitig eine Anhörung vor dem Nasdaq Hearings Panel zu beantragen. Der Antrag auf Anhörung setzt automatisch jegliche Aussetzung oder Delisting-Maßnahmen bis zur Entscheidung des Panels aus und verschafft dem Management zusätzliche Zeit, einen Compliance-Plan vorzulegen oder Unternehmensmaßnahmen (z. B. Reverse Split) zur Wiederherstellung des Aktienkurses zu ergreifen.

Finanzergebnisse, operative Updates oder Transaktionen wurden nicht mitgeteilt; das 6-K konzentriert sich ausschließlich auf den Listing-Status. Die Informationen werden durch Verweis in die bestehenden Registrierungserklärungen Form F-3 und S-8 des Unternehmens aufgenommen.

Positive
  • The company will request a Nasdaq Hearings Panel review, automatically staying any suspension or delisting action during the appeal process.
Negative
  • ADS bid price fell below $0.10 for 10 consecutive days, triggering immediate Nasdaq delisting procedures.
  • Company is already out of compliance with the $1.00 minimum bid price rule, compounding listing deficiencies and increasing risk to shareholders.

Insights

TL;DR: Nasdaq $0.10 bid-price breach escalates delisting threat; hearing buys limited time.

The second Nasdaq notice materially worsens NuCana’s liquidity and capital-markets outlook. Sub-$0.10 pricing suggests diminished investor confidence and potential non-compliance with brokers� custodial rules, further constraining trading volumes. While a hearing stay delays delisting, historically Panels grant 180-day extensions only with credible remediation plans such as a firmly scheduled reverse split. Absent rapid tangible catalysts, the risk of migration to OTC markets rises, likely pressuring the stock’s valuation and increasing financing costs.

TL;DR: Governance focus shifts to safeguarding U.S. listing; board must act swiftly.

The board now faces a time-sensitive governance challenge. Failure to maintain Nasdaq listing can limit institutional ownership, reduce transparency, and impair equity-based compensation programs referenced in the S-8 filings. The announced intent to request a hearing is procedurally correct, yet investors will expect a clearly articulated action plan—often a reverse split resolution requiring shareholder approval. Delay or indecision could signal weak governance oversight, potentially eroding stakeholder trust.

NuCana plc (NASDAQ: NCNA) è a rischio aumentato di esclusione dalla quotazione. La società ha comunicato che l'8 luglio 2025 ha ricevuto un secondo avviso da Nasdaq dopo che le sue American Depositary Shares hanno chiuso al di sotto di $0,10 per 10 giorni di contrattazione consecutivi (periodo terminato il 7 luglio 2025). Questo segue un avviso precedente del 18 giugno 2025 per essere scese sotto il prezzo minimo di offerta di $1,00, che ha concesso a NuCana tempo fino al 15 dicembre 2025 per tornare in conformità. Secondo la Regola di Quotazione Nasdaq 5810(c)(3)(A)(iii), scendere sotto i $0,10 comporta un'imminente esclusione dalla quotazione a meno che l’emittente non richieda un'udienza.
NuCana intende richiedere tempestivamente un'udienza davanti al Nasdaq Hearings Panel. La richiesta di udienza sospenderà automaticamente qualsiasi azione di sospensione o esclusione in attesa della decisione del Panel, concedendo alla direzione ulteriore tempo per presentare un piano di conformità o intraprendere azioni societarie (ad esempio, frazionamento inverso) per ripristinare il prezzo delle azioni.

Non sono stati inclusi risultati finanziari, aggiornamenti operativi o transazioni; il modulo 6-K si concentra esclusivamente sullo stato della quotazione. Le informazioni sono incorporate per riferimento nelle dichiarazioni di registrazione Form F-3 e S-8 esistenti della società.

NuCana plc (NASDAQ: NCNA) enfrenta un riesgo elevado de exclusión de la cotización. La compañía informó que el 8 de julio de 2025 recibió un segundo aviso de Nasdaq después de que sus American Depositary Shares cerraran por debajo de $0.10 durante 10 días hábiles consecutivos (periodo finalizado el 7 de julio de 2025). Esto sigue a un aviso anterior del 18 de junio de 2025 por caer por debajo del precio mínimo de oferta de $1.00, que otorgó a NuCana hasta el 15 de diciembre de 2025 para recuperar el cumplimiento. Según la Regla de Cotización Nasdaq 5810(c)(3)(A)(iii), caer por debajo de $0.10 genera una exclusión inminente a menos que el emisor solicite una audiencia.
NuCana tiene la intención de solicitar oportunamente una audiencia ante el Nasdaq Hearings Panel. La solicitud de audiencia suspenderá automáticamente cualquier acción de suspensión o exclusión mientras se espera la decisión del Panel, dando a la dirección tiempo adicional para presentar un plan de cumplimiento o realizar acciones corporativas (por ejemplo, una división inversa) para restaurar el precio de las acciones.

No se incluyeron resultados financieros, actualizaciones operativas ni transacciones; el formulario 6-K se centra exclusivamente en el estado de la cotización. La información se incorpora por referencia en las declaraciones de registro Form F-3 y S-8 existentes de la compañía.

NuCana plc (NASDAQ: NCNA)ëŠ� ìƒìž¥íì§€ 위험ì� 높아지ê³� 있습니다. 회사ëŠ� 2025ë…� 7ì›� 8ì�, 미국예íƒì¦ì„œ(ADS)ì� 종가가 10거래ì� ì—°ì†ìœ¼ë¡œ $0.10 미만ì� 기ë¡í•� ê²ƒì— ëŒ€í•� Nasdaq으로부í„� ë‘� 번째 통지ë¥� 받았다고 ë°í˜”습니ë‹�(기간 종료ì�: 2025ë…� 7ì›� 7ì�). ì´ëŠ” 2025ë…� 6ì›� 18ì¼ì— $1.00ì� 최소 ìž…ì°°ê°€ 미만으로 떨어ì§� ê²ƒì— ëŒ€í•� ì²� 번째 통지ì—� ì´ì€ 것입니다. ì� 통지ì—� ë”°ë¼ ±·³Ü°ä²¹²Ô²¹µç� 2025ë…� 12ì›� 15ì¼ê¹Œì§€ 규정 준수를 회복해야 합니ë‹�. Nasdaq ìƒìž¥ 규칙 5810(c)(3)(A)(iii)ì—� 따르ë©� $0.10 미만으로 떨어지ë©� 발행사가 청문회를 요청하지 않는 í•� 즉ê°ì ì¸ ìƒìž¥í지가 촉발ë©ë‹ˆë‹�.
±·³Ü°ä²¹²Ô²¹µç� ì ì‹œì—� Nasdaq 청문íš� 패ë„ì—� 청문íš� 요청ì� í•� 계íšìž…니ë‹�. 청문íš� ìš”ì²­ì€ íŒ¨ë„ì� ê²°ì •ì� ë‚´ë ¤ì§� 때까지 모든 ì •ì§€ ë˜ëŠ” ìƒìž¥íì§€ 조치ë¥� ìžë™ìœ¼ë¡œ 중단시키ë©�, ê²½ì˜ì§„ì—ê²� 준ìˆ� 계íšì� 제시하거ë‚� 주가 회복ì� 위한 기업 조치(ì˜�: 액면병합)ë¥� 추진í•� 추가 시간ì� 제공합니ë‹�.

재무 실ì , ìš´ì˜ ì—…ë°ì´íЏ ë˜ëŠ” 거래 ê´€ë � ë‚´ìš©ì€ í¬í•¨ë˜ì§€ 않았으며, 6-K 보고서는 ìƒìž¥ ìƒíƒœì—ë§Œ 집중ë˜ì–´ 있습니다. ì� ì •ë³´ëŠ� 회사ì� 기존 Form F-3 ë°� S-8 ë“±ë¡ ì„œë¥˜ì—� 참조ë¡� í¬í•¨ë©ë‹ˆë‹�.

NuCana plc (NASDAQ : NCNA) fait face à un risque accru de radiation. La société a révélé que, le 8 juillet 2025, elle a reçu un second avis de Nasdaq après que ses American Depositary Shares ont clôturé en dessous de 0,10 $ pendant 10 jours de bourse consécutifs (période terminée le 7 juillet 2025). Cela fait suite à un premier avis du 18 juin 2025 pour être tombé en dessous du prix d'offre minimum de 1,00 $, accordant à NuCana jusqu'au 15 décembre 2025 pour se remettre en conformité. Selon la règle de cotation Nasdaq 5810(c)(3)(A)(iii), un cours inférieur à 0,10 $ déclenche une radiation imminente, sauf si l’émetteur demande une audience.
NuCana a l'intention de demander en temps utile une audience devant le Nasdaq Hearings Panel. La demande d’audience suspendra automatiquement toute suspension ou radiation en attendant la décision du Panel, offrant à la direction un délai supplémentaire pour présenter un plan de conformité ou engager des actions d’entreprise (par exemple, un regroupement d’actions) pour rétablir le cours de l’action.

Aucun résultat financier, mise à jour opérationnelle ou transaction n’a été inclus ; le formulaire 6-K se concentre uniquement sur le statut de la cotation. Les informations sont incorporées par référence dans les déclarations d’enregistrement Form F-3 et S-8 existantes de la société.

NuCana plc (NASDAQ: NCNA) steht vor einem erhöhten Risiko der Delistung. Das Unternehmen gab bekannt, dass es am 8. Juli 2025 eine zweite Mitteilung von Nasdaq erhalten hat, nachdem seine American Depositary Shares an 10 aufeinanderfolgenden Handelstagen unter $0,10 geschlossen hatten (Zeitraum endete am 7. Juli 2025). Dies folgt auf eine frühere Mitteilung vom 18. Juni 2025 wegen Unterschreitens des Mindestgebotspreises von $1,00, die NuCana bis zum 15. Dezember 2025 Zeit gab, die Einhaltung wiederherzustellen. Nach Nasdaq Listing Rule 5810(c)(3)(A)(iii) führt ein Kurs unter $0,10 zu einer unmittelbar bevorstehenden Delistung, sofern der Emittent keine Anhörung beantragt.
NuCana beabsichtigt, rechtzeitig eine Anhörung vor dem Nasdaq Hearings Panel zu beantragen. Der Antrag auf Anhörung setzt automatisch jegliche Aussetzung oder Delisting-Maßnahmen bis zur Entscheidung des Panels aus und verschafft dem Management zusätzliche Zeit, einen Compliance-Plan vorzulegen oder Unternehmensmaßnahmen (z. B. Reverse Split) zur Wiederherstellung des Aktienkurses zu ergreifen.

Finanzergebnisse, operative Updates oder Transaktionen wurden nicht mitgeteilt; das 6-K konzentriert sich ausschließlich auf den Listing-Status. Die Informationen werden durch Verweis in die bestehenden Registrierungserklärungen Form F-3 und S-8 des Unternehmens aufgenommen.

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

(Commission File No. 001-38215)

 

 

NUCANA PLC

(Translation of registrant’s name into English)

 

 

3 Lochside Way

Edinburgh EH12 9DT

United Kingdom

(Address of registrant’s principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒   Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7): ☐

 

 
 


Other Events

As previously disclosed, on June 18, 2025, NuCana plc (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the bid price for of its American Depositary Shares (“ADSs”) had closed below the $1.00 per share minimum bid price threshold for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”), for the preceding 30 consecutive trading days. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was granted a 180-calendar day period, through December 15, 2025, to regain compliance with the Bid Price Requirement.

On July 8, 2025, the Company received a second written notice (the “Second Notice”) from Nasdaq stating that the bid price for the Company’s ADSs had closed below $0.10 per share for the 10 consecutive trading day period ended July 7, 2025. Accordingly, the Company was notified that, in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(iii), the Company was subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any suspension or delisting action pending the ultimate outcome of the hearing process.

The information contained in this Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, as amended (File No. 333-281576), and its Registration Statements on Form S-8 (File Nos. 333-223476 and 333-248135).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

NuCana plc
By:   /s/ Ian Webster
Name:   Ian Webster
Title:   Interim Chief Financial Officer

Date: July 9, 2025

FAQ

Why did Nasdaq issue a second delisting notice to NCNA?

NuCana’s ADSs traded below $0.10 for 10 consecutive days, violating Nasdaq Listing Rule 5810(c)(3)(A)(iii).

Does the hearing request prevent NuCana’s delisting?

Yes. A timely request for a Panel hearing stays suspension or delisting until a decision is reached.

How long does NuCana have to regain the $1.00 minimum bid price?

The earlier notice granted an extension through December 15, 2025 to meet the $1.00 requirement.

What options can NuCana pursue to regain compliance?

Typical remedies include a reverse stock split or corporate actions aimed at sustainably raising the share price.

Are there any financial results disclosed in this Form 6-K?

No. The filing pertains solely to Nasdaq listing compliance; no earnings or operational data were provided.
Nucana

NASDAQ:NCNA

NCNA Rankings

NCNA Latest News

NCNA Latest SEC Filings

NCNA Stock Data

20.23M
381.62M
0.3%
16.65%
0.44%
Biotechnology
Pharmaceutical Preparations
United Kingdom
GAITHERSBURG